Scoop has an Ethical Paywall
Licence needed for work use Learn More

Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search

 

The Insides Co. Partners With GBUK Group To Provide Chyme Reinfusion Devices To The United Kingdom & Ireland

The Insides™ Company is proud to announce it has partnered with GBUK Group to provide The Insides™ range of chyme reinfusion medical devices into the United Kingdom and Ireland.

This includes the award winning The Insides System that is used for treating patients with type 2 intestinal failure. In 2021 The Insides System won GOLD at the highly regarded international Medical Design Excellence Awards (MDEAs) in the Gastrointestinal and Genitourinary Devices Category.

Garth Sutherland, CEO of The Insides Company said “We are very pleased to announce this partnership with GBUK Group who are a leading provider of enteral nutritional products to the UK and Ireland. GBUK bring an extensive network of trusted relationships within the NHS.”

Mike Geering, CEO of GBUK Group Ltd said “"The team at GBUK are delighted to be partnering with The Insides Company and to be able to offer such an innovative product to patients and clinicians in the UK & Ireland. The Chyme reinfusion system will have a positive life changing impact on patients and GBUK are proud to be part of that".

About GBUK Group

GBUK Group, is an award-winning specialist company who are focused on the provision of enteral feeding, critical care and patient moving products. Within the Group, GBUK Enteral is the UK’s leading supplier enteral feeding tubes, syringes, and gastrostomy devices

Advertisement - scroll to continue reading

The GBUK Group’s success is founded on the pursuit of technical innovation and the provision of world-class products in terms of both quality and value.

About The Insides Company

The Insides Company is a leading designer and manufacturer of purpose-built chyme reinfusion solutions for patients with intestinal failure. The company’s devices demonstrate significant improvements in clinical and economic outcomes for patients requiring intestinal rehabilitation.

© Scoop Media

Advertisement - scroll to continue reading
 
 
 
Business Headlines | Sci-Tech Headlines

 
 
 
 
 
 
 
 
 
 
 
 

Join Our Free Newsletter

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.